Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

New research program for CRL-5861 in cancer

Feb. 22, 2001

BioNumerik partners with Asta Medica for oncology drug development

Feb. 22, 2001

Hollow fiber model used to study in vitro cytotoxic activity of CHS-828

Feb. 22, 2001

FeRx initiates phase I/II trial of MTC-DOX for metastatic liver cancer

Feb. 22, 2001

Preclinical data support clinical development of BN-80915, a lead homocamptothecin

Feb. 22, 2001

Hybrigenics and Servier to identify new targets for anticancer drugs

Feb. 21, 2001

Taisho presents new VEGF receptor antagonists with antiangiogenic/antitumor activity

Feb. 21, 2001

Orally active small-molecule GnRH antagonists presented by Neurocrine Biosciences

Feb. 21, 2001

Promising toxicity and pharmacokinetic findings emerge from phase Ia trial of doranidazole

Feb. 21, 2001

Ribozyme and Chiron begin phase II trial with Angiozyme for breast cancer

Feb. 21, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...